[Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old]
- PMID: 2970743
[Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old]
Abstract
A total of 10,971 children aged 3-15 years were immunized with live influenza vaccine (the variant intended for children), type A (H1N1). The vaccine proved to be nonreactogenic and produced no harmful effect on the child organism. The genetic stability of the vaccine strain and its high immunogenic activity were shown.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical